Surgical Innovations Group's shares tumbled Tuesday after the company said 2012 revenues were hit by manufacturing capacity constraints and delays in regulatory approvals in the final quarter.
Shares fell almost 15% on the morning of the announcement as the group said it expected total revenue last year to come to £7.6m, unchanged from 2011.
The designer and manufacturer of solutions for surgery said manufacturing capacity constraints its UK facility in Leeds and a delay in US regulatory approval impacted revenues towards the end of the financial year. As a result, revenues of £1.0m were not seen until January.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Nevertheless, trading improved 85% to £5.6m during the last half of the year, driven by an increase in product orders.
The company's SI Brand business represented 68% of overall revenues, compared to 62% in 2011.
Gross margins were anticipated to have improved by three basis points to 50.3%, up from 47.3% the year earlier.
Adjusted earnings before interest, tax, depreciation, and amortisation (EBITDA) for the period was projected to reach £2.85m, up from £2.8m.
The firm ended the year with short term borrowings of £1.4m against bank facilities provided by HSBC of £2.0m.
Graham Bowland, Chief Executive Officer, said: "I am pleased with the strong sales performance that we've achieved in the second half of the year.
"There is no doubt that the manufacturing capacity constraints we experienced in the final quarter of 2012 justify the need for our proposed new facility part funded by the award of the £5.0m regional growth fund."
RD
-
Saba Capital and Boaz Weinstein respond to investment trustsAs investment trust managers and industry experts accuse Saba of self-motivated opportunism, the hedge fund responds to specific "misleading claims" and sets out its stall
-
How to find top-quality companies with growing dividendsIan Mortimer, portfolio manager of Guinness Global Equity Income Fund, shares where he would put his money for sustainable and growing dividends
